P

Inventor

PARKER FABIENNE

FR12 patents
⚠️ This page may combine multiple inventors who share the name “PARKER FABIENNE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

RHONE POULENC SANTE

4 patents
US4777243AOct 11, 1988

Immuno stimulant substances derived from bovine casein and compositions containing the same

RHONE POULENC SANTE7 citations72
US4851509AJul 25, 1989

Biologically active substances and compositions containing the same

RHONE POULENC SANTE3 citations61
US4716151ADec 29, 1987

Tripeptides and their use

RHONE POULENC SANTE5 citations61
US4647554AMar 3, 1987

Biologically active substances from fibrinogen their preparation and compositions containing them

RHONE POULENC SANTE1 citations51

SANOFI SA

3 patents
US9676864B2Jun 13, 2017

Antibodies that specifically bind to the EphA2 receptor

SANOFI SA2 citations72
USRE47123ENov 13, 2018

EPHA2 receptor antagonist antibodies

SANOFI SA2 citations71
US8992912B2Mar 31, 2015

Methods of use for antibodies that specifically bind to the EphA2 receptor

SANOFI SA1 citations60

RHONE POULENC RORER SA

1 patent
US5886150AMar 23, 1999

Peptides capable of binding to the GAP protein SH3 domain, nucleotide sequences coding therefor, and preparation and use thereof

RHONE POULENC RORER SA41 citations90

BOUCHARD HERVE

1 patent
US8668910B2Mar 11, 2014

Antibodies that specifically bind to the EphA2 receptor

BOUCHARD HERVE5 citations81

BLANC VERONIQUE

1 patent
US8460667B2Jun 11, 2013

EPHA2 receptor antagonist antibodies

BLANC VERONIQUE8 citations77

AVENTIS PHARMA SA

1 patent
US7001980B1Feb 21, 2006

Monoclonal antibodies directed against the G3BP protein, and uses

AVENTIS PHARMA SA14 citations76

INST NAT SANTE RECH MED

1 patent
US4637997AJan 20, 1987

Hexapeptide, process for obtaining II and the pharmaceutical compositions containing II

INST NAT SANTE RECH MED1 citations46